Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
REVENUE:
Revenue	$ 523,848	$ 509,790	$ 489,735
OPERATING EXPENSES:
General and administrative expense, exclusive of depreciation expense shown below	39,770	40,259	38,117
Depreciation	14,449	15,294	16,476
Amortization	504	490	685
Other (income) expense, net	(9,953)	(850)	(722)
OPERATING INCOME	58,556	54,640	41,524
Interest expense	12,369	13,430	11,570
Income before income taxes	46,187	41,210	29,954
Income tax expense	14,034	4,185	10,296
Net income	32,153	37,025	19,658
Net income attributable to non-controlling interest	753	350	205
Net income attributable to Core Laboratories Inc.	$ 31,400	$ 36,675	$ 19,453
EARNINGS PER SHARE INFORMATION:
Basic earnings per share	$ 0.69	$ 0.79	$ 0.42
Basic earnings per share attributable to Core Laboratories Inc.	0.67	0.79	0.42
Diluted earnings per share	0.67	0.78	0.42
Diluted earnings per share attributable to Core Laboratories Inc.	$ 0.66	$ 0.77	$ 0.42
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING:
Basic	46,897	46,683	46,334
Diluted	47,685	47,523	46,813
Service [Member]
REVENUE:
Revenue	$ 388,205	$ 371,914	$ 346,974
OPERATING EXPENSES:
Cost of services and product sales exclusive of depreciation expense shown below	297,324	282,135	274,297
Product [Member]
REVENUE:
Revenue	135,643	137,876	142,761
OPERATING EXPENSES:
Cost of services and product sales exclusive of depreciation expense shown below	$ 123,198	$ 117,822	$ 119,358